AstraZeneca PLC (BCBA:AZN)

AstraZeneca Statistics

Total Valuation

AstraZeneca has a market cap or net worth of ARS 280.70 trillion. The enterprise value is 315.96 trillion.

Market Cap	280.70T
Enterprise Value	315.96T

Important Dates

The next estimated earnings date is Tuesday, July 29, 2025.

Earnings Date	Jul 29, 2025
Ex-Dividend Date	Feb 21, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.08%
Shares Change (QoQ)	-0.06%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.54B

Valuation Ratios

The trailing PE ratio is 33.66 and the forward PE ratio is 15.81.

PE Ratio	33.66
Forward PE	15.81
PS Ratio	4.76
PB Ratio	6.36
P/TBV Ratio	n/a
P/FCF Ratio	23.46
P/OCF Ratio	19.99
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.73, with an EV/FCF ratio of 26.40.

EV / Earnings	37.88
EV / Sales	4.31
EV / EBITDA	12.73
EV / EBIT	17.42
EV / FCF	26.40

Financial Position

The company has a current ratio of 0.90, with a Debt / Equity ratio of 0.77.

Current Ratio	0.90
Quick Ratio	0.69
Debt / Equity	0.77
Debt / EBITDA	1.70
Debt / FCF	2.84
Interest Coverage	10.16

Financial Efficiency

Return on equity (ROE) is 19.79% and return on invested capital (ROIC) is 11.73%.

Return on Equity (ROE)	19.79%
Return on Assets (ROA)	8.16%
Return on Invested Capital (ROIC)	11.73%
Return on Capital Employed (ROCE)	17.65%
Revenue Per Employee	625.68M
Profits Per Employee	88.44M
Employee Count	94,300
Asset Turnover	0.53
Inventory Turnover	1.72

Taxes

In the past 12 months, AstraZeneca has paid 1.62 trillion in taxes.

Income Tax	1.62T
Effective Tax Rate	16.26%

Stock Price Statistics

The stock price has decreased by -20.72% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-20.72%
50-Day Moving Average	42,307.50
200-Day Moving Average	42,520.88
Relative Strength Index (RSI)	56.52
Average Volume (20 Days)	617

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AstraZeneca had revenue of ARS 59.00 trillion and earned 8.34 trillion in profits. Earnings per share was 5,332.77.

Revenue	59.00T
Gross Profit	48.64T
Operating Income	14.60T
Pretax Income	9.97T
Net Income	8.34T
EBITDA	19.61T
EBIT	14.60T
Earnings Per Share (EPS)	5,332.77

Balance Sheet

The company has 5.79 trillion in cash and 34.04 trillion in debt, giving a net cash position of -28,246.14 billion.

Cash & Cash Equivalents	5.79T
Total Debt	34.04T
Net Cash	-28,246.14B
Net Cash Per Share	n/a
Equity (Book Value)	44.14T
Book Value Per Share	28,412.23
Working Capital	-3,208.57B

Cash Flow

In the last 12 months, operating cash flow was 14.04 trillion and capital expenditures -2,077.52 billion, giving a free cash flow of 11.97 trillion.

Operating Cash Flow	14.04T
Capital Expenditures	-2,077.52B
Free Cash Flow	11.97T
FCF Per Share	n/a

Margins

Gross margin is 82.44%, with operating and profit margins of 24.75% and 14.14%.

Gross Margin	82.44%
Operating Margin	24.75%
Pretax Margin	16.90%
Profit Margin	14.14%
EBITDA Margin	33.24%
EBIT Margin	24.75%
FCF Margin	20.28%

Dividends & Yields

This stock pays an annual dividend of 699.75, which amounts to a dividend yield of 1.55%.

Dividend Per Share	699.75
Dividend Yield	1.55%
Dividend Growth (YoY)	65.15%
Years of Dividend Growth	3
Payout Ratio	63.60%
Buyback Yield	-0.08%
Shareholder Yield	1.47%
Earnings Yield	2.97%
FCF Yield	4.26%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AstraZeneca has an Altman Z-Score of 3.08 and a Piotroski F-Score of 7.

Altman Z-Score	3.08
Piotroski F-Score	7